FDA approves new version of diabetes drug Mounjaro to be sold for weight loss

2023 11 08T174605Z 2114409469 RC2V30ADLT84 RTRMADP 3 HEALTH OBESITY USA LILLY 1200x800 1

FILE PHOTO: A box of Mounjaro, a tirzepatide injection drug used for treating type 2 diabetes made by Lilly is seen at Rock Canyon Pharmacy in Provo, Utah, U.S. March 29, 2023. REUTERS/George Frey/File Photo

Exit mobile version